In the ApoE4 background equivalent to ApoE knockout, mCRP increases CD31 phosphorylation to promote cerebrovascular damage via disrupting mitochondrial metabolism, enhancing oxidative phosphorylation and increasing the immune response, causing cerebrovascular neuroinflammation leading to the formation of AD pathological markers. Here, PECAM1 is linked to Alzheimer disease.